McDermott Will & Schulte, a global law firm

This issue of McDermott’s Healthcare Regulatory Check-Up highlights regulatory activity for February 2024. We discuss various regulatory developments, including guidance on the use of AI in coverage decisions and texting patient information in hospitals, as well as new regulations on the confidentiality of substance abuse patient records and telehealth prescription of opioids. We also discuss several criminal and civil enforcement resolutions and activities that involve alleged violations of the False Claims Act (FCA), Anti-Kickback Statue (AKS), HIPAA and other claims.This issue of McDermott’s Healthcare Regulatory Check-Up highlights regulatory activity for February 2024. We discuss various regulatory developments, including guidance on the use of AI in coverage decisions and texting patient information in hospitals, as well as new regulations on the confidentiality of substance abuse patient records and telehealth prescription of opioids. We also discuss several criminal and civil enforcement resolutions and activities that involve alleged violations of the False Claims Act (FCA), Anti-Kickback Statue (AKS), HIPAA and other claims.